BHC - Bausch Health Companies Inc.
Close
7.52
-0.495 -6.582%
Share volume: 0
Last Updated: Tue 24 Dec 2024 06:15:23 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
19.80%
PREVIOUS CLOSE
CHG
CHG%
$8.02
-0.50
-6.18%
Fundamental analysis
42%
Profitability
44%
Dept financing
50%
Liquidity
55%
Performance
36%
Performance
5 Days
0.80%
1 Month
-5.28%
3 Months
-6.23%
6 Months
10.74%
1 Year
1.07%
2 Year
18.96%
Key data
Stock price
$7.52
DAY RANGE
$7.43 - $8.02
52 WEEK RANGE
$5.45 - $11.46
52 WEEK CHANGE
-$2.84
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/31/2024
Company detail
CEO: Thomas J. Appio
Region: US
Website: bauschhealth.com
Employees: 19,900
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: bauschhealth.com
Employees: 19,900
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment provides dermatological products in United States; and Solta medical aesthetic devices internationally.
Recent news